|
In Breast and Prostate Cancer Cohort Consortium:
|
|
Breast and Prostate Cancer and Hormone-Related Gene Variant Study
Organizational Structure
To achieve the goals of the consortium, several working groups have been
created that coordinate the efforts within and across the participating
cohorts and scientific disciplines. These structures are:
- Steering Committee: The Steering Committee includes the four
principal investigators for the cooperative agreements that fund participation
of the cohorts in the BCP3 Study, the principal investigators of the
cohorts themselves (which are funded independent of this study), and
NCI Program staff as Ex Officio members. The Steering Committee coordinates
the activities of the research components, decides on a timeline for
specific subcomponents of the study (e.g., the order in which groups
of genes are genotyped), coordinates pooling of data, and distributes
parts of the pooled data analyses to BCP3 Study members.
- Secretariat: Drs. David Hunter and Elio Riboli were elected
co-chairs of the Steering Committee and serve as the Secretariat responsible
for coordinating meetings, conference calls, and communications with
NCI.
- Shared resources:
- Population Genetics Working Group
- Haplotype Determination Laboratories
- Genotyping Working Group
- Statistics Working Group
- Data Pooling Working Group
- Publications Working Group
- Community Web Site Working Group
|
|